[1]
Nasiri-Aghdam, M.; Garcia-Garduño, T.C.; Jave-Suárez, L.F. Celf family proteins in cancer: Highlights on the RNA-binding protein/noncoding RNA regulatory axis. Int. J. Mol. Sci., 2021, 22(20), 11056.
[2]
Ramírez-Velazco, A.; Aguayo-Orozco, T.A.; Figuera, L.; Rivera, H.; Jave-Suárez, L.; Aguilar-Lemarroy, A.; Torres-Reyes, L.A.; Córdova-Fletes, C.; Barros-Núñez, P.; Delgadillo-Pérez, S.; Dávalos-Rodríguez, I.P.; García-Ortiz, J.E. Williams-Beuren syndrome in Mexican patients confirmed by FISH and assessed by aCGH. J. Genet., 2019, 98(21), 34.
[3]
Bustos-Carpinteyro, A.R.; Oliveira, C.; Sousa, A.; Oliveira, P.; Pinheiro, H.; Carvalho, J.; Magaña-Torres, M.T.; Flores-Miramontes, M.G.; Aguilar-Lemarroy, A.; Jave-Suárez, L.F.; Peregrina-Sandoval, J.; Cruz-Ramos, J.A. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer. BMC Cancer, 2019, 19(114), 69.
[4]
Aco-Tlachi, M.; Carreño-López, R.; Martínez-Morales, P.L.; Maycotte, P.; Aguilar-Lemarroy, A.; Jave-Suárez, L.F.; Santos-López, G.; Reyes-Leyva, J.; Vallejo-Ruiz, V. Glycogene expression profiles based on microarray data from cervical carcinoma HeLa cells with partially silenced E6 and E7 HPV oncogenes. Infect. Agent. Cancer, 2018, 13(120), 25.
[5]
Pedraza-Brindis, E.J.; Sánchez-Reyes, K.; Hernández-Flores, G.; Bravo-Cuellar, A.; Jave-Suárez, L.F.; Aguilar-Lemarroy, A.; Gómez-Lomelí, P.; López-López, B.A.; Ortiz-Lazareno, P.C. Culture supernatants of cervical cancer cells induce an M2 phenotypic profile in THP-1 macrophages. Cell. Immunol., 2016, 310, 42-52.
[6]
Olimón-Andalón, V.; Aguilar-Lemarroy, A.; Ratkovich-González, S.; Uribe-López, A.; Mariscal-Ramírez, I.; Delgadillo-Cristerna, R.; Ortiz-Lazareno, P.; Hernández-Flores, G.; de Celis, R.; Bravo-Cuellar, A.; Jave-Suárez, L.F. Proapoptotic CD95L levels in normal human serum and sera of breast cancer patients. Tumour Biol., 2015, 36(5), 3669-3678.
[7]
Sánchez-Reyes, K.; Bravo-Cuellar, A.; Hernández-Flores, G.; Lerma-Díaz, J.M.; Jave-Suárez, L.F.; Gómez-Lomelí, P.; De Celis, R.; Aguilar-Lemarroy, A.; Domínguez-Rodríguez, J.R.; Ortiz-Lazareno, P.C. Cervical cancer cell supernatants induce a phenotypic switch from U937-derived macrophage-activated M1 state into M2-like suppressor phenotype with change in toll-like receptor profile. BioMed Res. Int., 2014, 2014683068
[8]
Bravo-Cuellar, A.; Hernández-Flores, G.; Lerma-Díaz, J.M.; Domínguez-Rodríguez, J.R.; Jave-Suárez, L.F.; De Célis-Carrillo, R.; Aguilar-Lemarroy, A.; Gómez-Lomeli, P.; Ortiz-Lazareno, P.C. Pentoxifylline and the proteasome inhibitor MG132 induce apoptosis in human leukemia U937 cells through a decrease in the expression of Bcl-2 and Bcl-XL and phosphorylation of p65. J. Biomed. Sci., 2013, 20(1), 13.
[9]
González-Hernández, L.A.; Jave-Suarez, L.F.; Fafutis-Morris, M.; Montes-Salcedo, K.E.; Valle-Gutierrez, L.G.; Campos-Loza, A.E.; Enciso-Gómez, L.F.; Andrade-Villanueva, J.F. Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: A double-blind randomized controlled pilot trial. Nutr. J., 2012, 11(1), 90.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Current Cancer Therapy Reviews
Current Drug Safety
Current Drug Targets
Recent Patents on Anti-Cancer Drug Discovery
Letters in Drug Design & Discovery
Current Drug Discovery Technologies
Current Radiopharmaceuticals
Related Books
Science of Spices and Culinary Herbs - Latest Laboratory, Pre-clinical, and Clinical Studies
Frontiers in Clinical Drug Research - Anti-Cancer Agents
Advances in Organic Synthesis
Frontiers in Natural Product Chemistry
Recent Advances in Analytical Techniques
Frontiers in Drug Design and Discovery
NEOPLASIA and FERTILITY
Therapeutic Use of Plant Secondary Metabolites
Frontiers in Computational Chemistry
Frontiers in Bioactive Compounds
Article Metrics
1